Lancet Study: Russia’s Sputnik V Vaccine 91.6% Effective

1
>>Follow Matzav On Whatsapp!<<

Russia’s Sputnik V vaccine is 91.6% effective against symptomatic COVID-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the shot, which Moscow is already rolling out.

Sputnik V — named after the Soviet-era satellite — was approved in Russia months before results from its final-stage clinical trials were published, leading to scepticism from experts.

But the new analysis of data from 20,000 participants in Phase 3 trials suggests that the two-dose vaccination offers more than 90% efficacy against symptomatic COVID-19.

“The development of the Sputnik V vaccine has been criticised for unseemly haste, corner cutting, and an absence of transparency,” said an independent Lancet commentary by Ian Jones of the University of Reading and Polly Roy of the London School of Hygiene and Tropical Medicine.

“But the outcome reported here is clear and the scientific principle of vaccination is demonstrated, which means another vaccine can now join the fight to reduce the incidence of COVID-19.”

Read more at NEWSMAX.

{Matzav.com}


1 COMMENT

  1. So now Israel will be accused of genocide for allowing the Palestinians to use the Sputnik V vaccine that the Palestinians want to use, rather the Biontech/Pfizer vaccine that is being used in Israel, becuse the Sputnik V vaccine is only 92% effective and the Biontech/Pfizer vaccine is 95% effective.

LEAVE A REPLY

Please enter your comment!
Please enter your name here